1 – 9 of 9
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma
(
- Contribution to journal › Article
- 2022
-
Mark
PD‐L1 Expression in Non‐Small Cell Lung Cancer Specimens : Association with Clinicopathological Factors and Molecular Alterations
(
- Contribution to journal › Article
-
Mark
Difficulties in diagnostics of lung tumours in biopsies : An interpathologist concordance study evaluating the international diagnostic guidelines
(
- Contribution to journal › Article
- 2021
-
Mark
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Real-world diagnostic accuracy and use of immunohistochemical markers in lung cancer diagnostics
(
- Contribution to journal › Article
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
(
- Contribution to journal › Article
- 2017
-
Mark
Determination of PD-L1 expression in effusions from mesothelioma by immuno-cytochemical staining
(
- Contribution to journal › Article
- 2015
-
Mark
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
(
- Contribution to journal › Scientific review
-
Mark
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
(
- Contribution to journal › Article